Literature DB >> 27832872

Curbing the circulation of counterfeit medicines in Nigeria.

Omotayo Fatokun1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27832872     DOI： 10.1016/S0140-6736(16)32121-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Combatting Substandard and Counterfeit Medicines in the Nigerian Drug Market: How Industrial Pharmacists Can Rise Up to the Challenge.

Authors:  Melody Okereke; Ignatius Anukwu; Sola Solarin; Mazi Sam Ohuabunwa
Journal:  Innov Pharm       Date:  2021-06-10

2.  The economic impact of substandard and falsified antimalarial medications in Nigeria.

Authors:  Sarah M Beargie; Colleen R Higgins; Daniel R Evans; Sarah K Laing; Daniel Erim; Sachiko Ozawa
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

Review 3.  Medicines and vaccines supply chains challenges in Nigeria: a scoping review.

Authors:  Victory O Olutuase; Chinwe J Iwu-Jaja; Cynthia P Akuoko; Emmanuel O Adewuyi; Vishnu Khanal
Journal:  BMC Public Health       Date:  2022-01-05       Impact factor: 3.295

4.  Stakeholders' perspectives and willingness to institutionalize linkages between the formal health system and informal healthcare providers in urban slums in southeast, Nigeria.

Authors:  Obinna Onwujekwe; Chinyere Mbachu; Victor Onyebueke; Pamela Ogbozor; Ifeyinwa Arize; Chinyere Okeke; Uche Ezenwaka; Tim Ensor
Journal:  BMC Health Serv Res       Date:  2022-04-30       Impact factor: 2.908

Review 5.  Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations.

Authors:  Huma Rasheed; Ludwig Hoellein; Khalid Saeed Bukhari; Ulrike Holzgrabe
Journal:  J Pharm Policy Pract       Date:  2019-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.